YK
Yury Kukushkin
OtherActiveInvestment Director at JDRF T1D fund
Boston, United StatesFounded 2022
23
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Yury Kukushkin.
Investment Thesis & Strategy
Yury Kukushkin, as Investment Director at JDRF T1D Fund, invests in various stages of biotech companies, specifically those focused on type 1 diabetes research and treatments. They seek companies developing innovative solutions to prevent, treat, and cure type 1 diabetes.
Investment Activity
Deals per year over the last 5 years
2
20174
20184
20191
20201
2021Portfolio Companies
Selected investments from their portfolio of 23 companies
D
DiogenX
Biotech · Seed, 2021
V
Veralox Therapeutics
Biotech · Seed, 2020
K
Kriya Therapeutics
Biotech · Series B, 2019
S
Sonoma BioTherapeutics
Biotech · Series A, 2019
E
Enthera
Biotech · Seed, 2019
i
i2o Therapeutics
Biotech · Seed, 2019
I
IMTherapeutics
Biotech · Seed, 2018
I
Inversago Pharma
Biotech · Series A, 2018
R
Repertoire Immune Medicines
Biotech · Series B, 2018
C
Capillary Biomedical
Healthcare · Seed, 2018
T
Tetragenetics
Biotech · Seed, 2017
B
Bigfoot Biomedical
Healthcare · Series B, 2017
Frequently Asked Questions
Yury Kukushkin invests across multiple stages. Sign up to view detailed stage data.